BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 19877309)

  • 21. Emerging artemisinin resistance in the border areas of Thailand.
    Na-Bangchang K; Karbwang J
    Expert Rev Clin Pharmacol; 2013 May; 6(3):307-22. PubMed ID: 23656342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of artemisinin-based combination therapy for treatment of persons with uncomplicated Plasmodium falciparum malaria in West Sumba District, East Nusa Tenggara Province, Indonesia, and genotypic profiles of the parasite.
    Asih PB; Dewi RM; Tuti S; Sadikin M; Sumarto W; Sinaga B; van der Ven AJ; Sauerwein RW; Syafruddin D
    Am J Trop Med Hyg; 2009 Jun; 80(6):914-8. PubMed ID: 19478248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of primaquine on the elimination of sexual forms of Plasmodium falciparum in vivo].
    Menéndez Capote RL; López Chávez AU
    Rev Cubana Med Trop; 1994; 46(3):164-6. PubMed ID: 9768257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of multiple copies of pfmdr1 gene in Papua New Guinea.
    Hodel EM; Marfurt J; Müller D; Rippert A; Borrmann S; Müller I; Reeder JC; Siba P; Genton B; Beck HP
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1151-3. PubMed ID: 18599099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An analytical presentation of drug resistance in Plasmodium falciparum and guidelines to formulate a drug strategy.
    Pandya AP; Sharma RS; Sahu GC
    J Commun Dis; 1995 Mar; 27(1):44-54. PubMed ID: 7636152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rare presentation of falciparum malaria.
    Jain D; Srivastave S; Singhal SS
    J Assoc Physicians India; 1995 Aug; 43(8):582. PubMed ID: 8772991
    [No Abstract]   [Full Text] [Related]  

  • 28. P. falciparum strain resistance to drugs. New drug trials.
    de Souza JM
    Rev Inst Med Trop Sao Paulo; 1992 Apr; 34 Suppl 9():S10-5. PubMed ID: 1340625
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular Markers and In Vitro Susceptibility to Doxycycline in Plasmodium falciparum Isolates from Thailand.
    Gaillard T; Sriprawat K; Briolant S; Wangsing C; Wurtz N; Baragatti M; Lavina M; Pascual A; Nosten F; Pradines B
    Antimicrob Agents Chemother; 2015 Aug; 59(8):5080-3. PubMed ID: 26055380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicases - feasible antimalarial drug target for Plasmodium falciparum.
    Tuteja R
    FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definition of hyperparasitemia in severe falciparum malaria should be updated.
    Wilairatana P; Tangpukdee N; Krudsood S
    Asian Pac J Trop Biomed; 2013 Jul; 3(7):586. PubMed ID: 23835631
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mefloquine resistance in Plasmodium falciparum malaria].
    Garavelli PL
    Recenti Prog Med; 2003; 94(7-8):343. PubMed ID: 12868243
    [No Abstract]   [Full Text] [Related]  

  • 33. Positive blood culture with Plasmodium falciparum: case report.
    de Vries JJ; van Assen S; Mulder AB; Kampinga GA
    Am J Trop Med Hyg; 2007 Jun; 76(6):1098-9. PubMed ID: 17556617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biological and epidemiological basis of drug resistance in malaria parasites.
    Wernsdorfer WH
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():123-9. PubMed ID: 1364857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skirmishing over the scope of the threat.
    Roberts L
    Science; 2016 Apr; 352(6284):403. PubMed ID: 27102460
    [No Abstract]   [Full Text] [Related]  

  • 36. Artemisinin (Qinghaosu): a mesmerizing drug that still puzzles.
    Zhou B
    Sci China Life Sci; 2015 Nov; 58(11):1151-3. PubMed ID: 26501377
    [No Abstract]   [Full Text] [Related]  

  • 37. The threat of artemisinin-resistant malaria.
    Dondorp AM; Fairhurst RM; Slutsker L; Macarthur JR; Breman JG; Guerin PJ; Wellems TE; Ringwald P; Newman RD; Plowe CV
    N Engl J Med; 2011 Sep; 365(12):1073-5. PubMed ID: 21992120
    [No Abstract]   [Full Text] [Related]  

  • 38. Plasmodium falciparum ATP6 not under selection during introduction of artemisinin combination therapy in Peru.
    Woodrow CJ; Bustamante LY
    Antimicrob Agents Chemother; 2010 May; 54(5):2280; author reply 2280-1. PubMed ID: 20404129
    [No Abstract]   [Full Text] [Related]  

  • 39. [Is the in vivo test for resistance to antimalarial agents in malaria as defined by the WHO valid?].
    Cabezos J; Bada JL; Asmarats L
    Med Clin (Barc); 1992 Oct; 99(11):436. PubMed ID: 1469944
    [No Abstract]   [Full Text] [Related]  

  • 40. Artemisinin-Resistant and HRP-Negative Malaria Parasites in Africa.
    Greenwood B
    N Engl J Med; 2023 Sep; 389(13):1162-1164. PubMed ID: 37754281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.